AbstractObjectivesResearch on the general prescription patterns of insured herbal preparations in Korea has been limited. This study aimed to analyze prescription patterns of insured herbal preparations, utilizing the National Health Insurance Service (NHIS) sample cohort 2.0 data from 2010 to 2019.
MethodsNHIS sample cohort 2.0 database, which represents a sample of 2.2% of the Korean population, was analyzed. We analyzed data related to prescriptions recognized as insured herbal preparations. Variables included patient demographics, diagnosis codes, prescription details, and healthcare institution characteristics. We examined trends over the decade, focusing on herbal formulae and single herb extracts.
ResultsDuring the study period, 275,358 patients visited Korean traditional medicine clinics and received at least one prescription of herbal preparations, representing 27.5% of the total sample. The number of prescriptions increased by 209%, from 34,621 in 2010 to 72,553 in 2019. Females accounted for 67% of these prescriptions, and 77% were for patients aged 70 and older. The top ten herbal formulae (TTHF), including Ojeok-san and Gungha-tang, constituted 76% of all prescriptions. Herbal formulae were used more frequently than single herb extracts, with certain prescriptions being commonly utilized. There was a notable focus on musculoskeletal disorders, with low back pain being the most common diagnosis.
ConclusionThe study demonstrates a significant increase in the use of insured herbal preparations, primarily in small clinics and among the elderly. Prescription patterns showed a preference for specific single herb extracts and herbal formulae, with consistent trends over time. These findings provide valuable insights for future clinical research and policy development, particularly as herbal medicine's role in the national healthcare system continues to expand.
참고문헌1. Ministry of Health and Welfare. (2014). March. 18. Pharmaceutical Affairs Act. Act No. 12450, Partial Amendment;
2. Ministry of Food and Drug Safety. (2014). March. 3. Regulation on Herbal Medicinal Preparations(Crude Drugs) Approval and Notification. Notification No. 2014–100, Partial Amendment;
 3. Kim J.-H., Cho S.-Y., Han S.-Y., Park S.-D., & Kim Y.-K.(2015). Suggestion about Modernized Classification of Herbal Medicinal Preparations in Dual Medical Systems. Journal of Korean Medicine;36(1):61-74.
https://doi.org/10.13048/jkm.15006
4. Kim C., & Shin H.(2023). Analysis of the current status of quantitative literature evidence for the prescription of 56 herbal medicines covered by health insurance. Journal of Korean Medicine;44(3):189-200.
https://doi.org/10.13048/jkm.23041
5. Ministry of Health and Welfare. 2024. Criteria for calculating the upper limit of herbal medicines (based on determination and adjustment of medicines). Ministry of Health and Welfare;
https://www.law.go.kr/LSW/admRulLsInfoP.do?admRulSeq=2100000112431
6. Akom news. 2024. Reevaluating the upper limit of herbal medicines and changing the list of benefits “in progress.”.
www.akomnews.com https://www.akomnews.com/bbs/board.php?bo_table=news&wr_id=55535
7. Drug control department. 2021. Benefit Drug Claims Status. HIRA;Available from: https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020045010000&brdScnBltNo=4&brdBltNo=2367#none
8. Jeong Woo Sung, Shin Woo Cheol, Hong Ik Hwan, Choi Jung Uk, & Kim Yun-Kyung. (2017). A survey on additional needs for herbal preparations in national health insurance service. Herbal Formula Science;25(3):375-390.
https://doi.org/10.14374/HFS.2017.25.3.375
9. Korean Medicine Yearbook. 2021. National Institute of Korean Medicine Development;Available from: https://nikom.or.kr/nikom/board/index.do?menu_idx=38&manage_idx=53
 10. Yang P.-R., Liang H.-F., Chu Y.-H., Chen P.-C., & Lin Y.-Y.(2015). Frequencies and prescription patterns of traditional Chinese medicine use among elderly patients in Taiwan: A population-based study. Journal of Ethnopharmacology;169328-334.
https://doi.org/10.1016/j.jep.2015.04.046
 11. Liang H.-F., Yang Y.-H., Chen P.-C., Kuo H.-C., Chang C.-H., & Wang Y.-H., et al(2018). Prescription patterns of traditional Chinese medicine amongst Taiwanese children: A population-based cohort study. BMC Complementary and Alternative Medicine;18(1):191
https://doi.org/10.1186/s12906-018-2261-2
12. Wen S.-H., Chang W.-C., Shen H.-S., & Wu H.-C.(2020). Prescription patterns and factors influencing the use of Chinese herbal medicine among pregnant women in Taiwan: A population-based retrospective study. BMC Complementary Medicine and Therapies;20(1):240
https://doi.org/10.1186/s12906-020-03032-0
13. Yang Y.-H., Chen P.-C., Wang J.-D., Lee C.-H., & Lai J.-N.(2009). Prescription pattern of traditional Chinese medicine for climacteric women in Taiwan. Climacteric : The Journal of the International Menopause Society;12(6):541-547.
https://doi.org/10.3109/13697130903060081
14. Lin M.-J., Chen H.-W., Liu P.-H., Cheng W.-J., Kuo S.-L., & Kao M.-C.(2019). The prescription patterns of traditional Chinese medicine for women with polycystic ovary syndrome in Taiwan: A nationwide population-based study. Medicine;98(24):e15890
https://doi.org/10.1097/MD.0000000000015890
15. Brodie M. J.(2022). Prescription patterns among people with epilepsy. Epilepsy & Behavior;130108690
https://doi.org/10.1016/j.yebeh.2022.108690
16. Chang Y.-Y., Tsai Y.-T., Lai J.-N., Yeh C.-H., & Lin S.-K.(2014). The traditional Chinese medicine prescription patterns for migraine patients in Taiwan: A population-based study. Journal of Ethnopharmacology;151(3):1209-1217.
https://doi.org/10.1016/j.jep.2013.12.040
17. Lee Y.-S., Kwon S., Chae Y., Jang B.-H., & Ko S.-G.(2018). A retrospective cohort study on the outcomes of ischemic stroke patients with adjuvant Korean Medicine treatment. Scientific Reports;8(1):1656
https://doi.org/10.1038/s41598-018-19841-w
18. Kim C. H., Choi Y., Chung C. K., Kim K.-J., Shin D. A., & Park , et al(2021). Nonsurgical treatment outcomes for surgical candidates with lumbar disc herniation: A comprehensive cohort study. Scientific Reports;11(1):3931
https://doi.org/10.1038/s41598-021-83471-y
19. Moon H., Kim M., Hwang D., Jang J., Lee J., & Shin J., et al(2020). BJOG: An International Journal of Obstetrics & Gynaecology;127(1):79-86.
https://doi.org/10.1111/1471-0528.15925
20. Lee B., Ahn E. K., & Yang C.(2022). Herbal Medicine Prescriptions for Functional Dyspepsia: A Nationwide Population-Based Study in Korea. Evidence-Based Complementary and Alternative Medicine : eCAM;20223306420
https://doi.org/10.1155/2022/3306420
21. Lee J., Lee J. S., Park S.-H., Shin S. A., & Kim K.(2016). Cohort Profile: The National Health Insurance Service–National Sample Cohort (NHIS-NSC), South Korea. International Journal of Epidemiology;dyv319
https://doi.org/10.1093/ije/dyv319
22. Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., & Luthi J.-C., et al(2005). Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data. Medical Care;43(11):1130-1139.
https://doi.org/10.1097/01.mlr.0000182534.19832.83
23. Kim K. H.(2010). Comparative Study on Three Algorithms of the ICD-10 Charlson Comorbidity Index with Myocardial Infarction Patients. Journal of Preventive Medicine and Public Health;43(1):
24. KOSIS. 2022. Census of Housing Results. Statistics Korea;Available from: https://kosis.kr/visual/populationKorea/PopulationDashBoardMain.do
25. Lee J. E., Choi J., Lim H. S., Kim J. H., Cho J. H., & Kim G. S., et al(2017). The Prevalence and Incidence of Parkinson’s Disease in South Korea: A 10-Year Nationwide Population–Based Study. Journal of the Korean Neurological Association;35(4):191-198.
https://doi.org/10.17340/jkna.2017.4.1
26. Lee Y.2019. Statistics on seniors in Korea. Statistics Korea;Available from: https://kostat.go.kr/board.es?mid=a10301060500&bid=10820&tag=&act=view&list_no=377701&ref_bid=
27. Ministry of Health and Welfare. 2017. Senior Outpatient Copayment Improvements.
https://blog.naver.com/mohw2016/221133876561
28. Ministry of Health and Welfare. 2024. Ministry of Health and Welfare Notice No. 2009–214_Indication for each prescription based on herbal medicines. Ministry of Health and Welfare;
https://www.mohw.go.kr/board.es?mid=a10409020000&bid=0026&act=view&list_no=1481950&tag=&nPage=1
29. Ang L., Lee H. W., Kim A., Choi J.-Y., & Lee M. S.(2021). Network Analysis of Herbs Recommended for the Treatment of COVID-19. Infection and Drug Resistance;141833-1844.
https://doi.org/10.2147/IDR.S305176
30. Negri Rogério G.2020. Dendrogram. Springer International Publishing;1-3.
https://doi.org/10.1007/978-3-030-26050-7_83-2
|
|
||||||||||||||||||||||||||||||||
|
|||||
PDF Links
Full text via DOI
PubReader
Download Citation 
Print 
